MJBizDaily
US marijuana MSO Curaleaf plots $272 million hostile takeover of Aurora Cannabis
Featured
Latest Posts
Embattled CannTrust halts marijuana sales; Canada’s supply shortfall could worsen
CannTrust Holdings halted all sales of cannabis products while Canada's federal regulator inspects its Vaughan, Ontario, manufacturing facility.
News July 12
MJBizDaily, Headset partner for exclusive cannabis retail data
Anne Holland Ventures, the parent company of Marijuana Business Daily, and Seattle-based data analytics firm Headset on Thursday announced a new partnership in which MJBizDaily can access Headset’s real-time, retail-derived industry data…
News July 11
Pennsylvania adds anxiety, Tourette syndrome to medical marijuana conditions list
Pennsylvania regulators have added two conditions to the list of health ailments that qualify for treatment with medical marijuana, which could result in an uptick in sales for MMJ firms.
News July 11
Ohio regulators claim two medical cannabis dispensaries violated rules
Ohio regulators are cracking down on two medical marijuana dispensaries, alleging the retailers violated state rules involving ownership issues. Greenleaf Apothecaries, which does business as The Botanist, and Harvest of…
News July 11
Deal Watch: Cannabis capital raises cool but still way ahead of 2018 pace
While the hot streak of capital raises may have cooled slightly in recent weeks, the North American cannabis industry is still far outpacing last year in terms of overall money…
News July 11
Demetrix raises $50 million to research synthetic cannabinoid production
California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production.
News July 11
California marijuana manufacturer charged with toxic waste dumping
A California cannabis company and two of its executives face federal criminal charges for dumping 1,500 pounds of toxic waste. The charges against WellGreensCA stem from alleged violations of Environmental…
News July 11
Biosynthesis may create disruption, opportunities in the cannabis industry
Biosynthesis - the mass production of specific cannabinoids in a lab setting - might be setting up to be the next big disruptor for the cannabis industry.
News July 11
Biosynthesis: The Next Cannabis Market Disruptor?
Biosynthesis - the mass production of specific cannabinoids in a lab setting - might be setting up to be the next big disruptor for the cannabis industry. In cannabis, the…
News July 11
Latest Sponsored
